Literature DB >> 29162351

Refining the Assessment and Implications of AR-V7 in Castrate-resistant Prostate Cancer.

Megan Crumbaker1, Richard Savdie2, Anthony M Joshua3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29162351     DOI： 10.1016/j.eururo.2017.11.005

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review.

Authors:  Alessandro Sciarra; Alessandro Gentilucci; Ida Silvestri; Stefano Salciccia; Susanna Cattarino; Susanna Scarpa; Antonio Gatto; Viviana Frantellizzi; Magnus Von Heland; Gian Piero Ricciuti; Francesco Del Giudice; Martina Maggi
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.